Clinical trial
MAST - Magnesium for Sickle Cell Acute Crisis in Children
NCT00313963 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00313963 |
|---|---|
| Title | MAST - Magnesium for Sickle Cell Acute Crisis in Children |
| Official title | MAST - Magnesium for Sickle Cell Acute Crisis in Children |
| Lead sponsor | The Hospital for Sick Children, Other |
| Collaborators | The Physicians' Services Incorporated Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell |
| Intervention type | Drug |
| Interventions | Magnesium Sulfate, Normal Saline |
| Enrollment | 120 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Jul 1, 2013 |
| First posted | Apr 12, 2006 |
| Last update posted | Aug 13, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: